{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:42Z","timestamp":1747207362920,"version":"3.40.5"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Hospital acquired (HA) infections are caused due to E. coliwhich is resistant to multiple drugs particularly to fluroquinolone class of drugs. Urinary tract infections (UTI) affects people in the community and in hospitals. 150 million people per annum are suffering from UTI worldwide.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>: In this present study, we designed 36 novel coumarin derivatives, also we predicted\npharmacokinetic and toxicity parameters. Docking studies were also carried out and all the compounds\nwere evaluated for antibacterial activity against resistant quinolone E. coli strain ATCC\n25922. It was interesting to note that the introduction of electron-withdrawing group on the aromatic\nring resulted in compounds with an increased antibacterial activity, which is observed in\ncompound 6 (with 4-nitro substitution), compound 23 (chloro) and compound 30 (chloro, nitro).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>From the MIC results, it was observed that compounds 6, 23 and 30 showed higher activity\nwith 0.5\u03bcg\/ml, 0. 12 \u03bcg\/ml, 0.5 \u03bcg\/ml respectively. Docking studies were performed with the\nactive site of DNA gyrase (PDB ID: 4CKK). The maximum binding energy was found to be -10.7\nKcal\/mol.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> From the study, it was found that 3 compounds were potentially active against quinolone-\nresistant E. coli strains. This study can further be extended for in vivo evaluation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409916666200131142619","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T14:09:17Z","timestamp":1580479757000},"page":"201-213","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Design, Synthesis, Docking and Biological Evaluation of Novel 4-hydroxy Coumarin Derivatives"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-2235","authenticated-orcid":true,"given":"N.","family":"Ramalakshmi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. BaidMetha College of Pharmacy, Thoraipakkam, Chennai-97, Tamil Nadu,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-4840","authenticated-orcid":true,"given":"S.R.","family":"Chitra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. BaidMetha College of Pharmacy, Thoraipakkam, Chennai-97, Tamil Nadu,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-730X","authenticated-orcid":true,"given":"P.","family":"Manimegalai","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, C.L. BaidMetha College of Pharmacy, Thoraipakkam, Chennai-97, Tamil Nadu,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-1498","authenticated-orcid":true,"given":"S.","family":"Arunkumar","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, Gulf Medical University, Ajmaan,United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/976273","volume":"2012","author":"Dalhoff A.","year":"2012","unstructured":"Dalhoff A.; Global fluoroquinolone resistance epidemiology and implictions for clinical use. Interdiscip Perspect Infect Dis 2012,2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jtumed.2015.02.009","volume":"10","author":"Rath S.","year":"2015","unstructured":"Rath S.; Padhy R.N.; Prevalence of fluoroquinolone resistance in Escherichia coli in an Indian teaching hospital and adjoining communities. J Taibah Uni Med Sci 2015,10(4),504-508","journal-title":"J Taibah Uni Med Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12879-015-1282-4","volume":"15","author":"Fasugba O.","year":"2015","unstructured":"Fasugba O.; Gardner A.; Mitchell B.G.; Mnatzaganian G.; Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis 2015,15(1),545","journal-title":"BMC Infect Dis"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/cid\/cis502","volume":"55","year":"2012","unstructured":"Critically important antimicrobials for human medicine 3rd Revision 2011. WHO Document Production Services, Geneva, Switzerland. Clin Infect Dis WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR)2012,55,712-719","journal-title":"Clin Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095864","volume":"9","author":"Zurfluh K.","year":"2014","unstructured":"Zurfluh K.; Abgottspon H.; H&#xE4;chler H.; N&#xFC;esch-Inderbinen M.; Stephan R.; Quinolone resistance mechanisms among extended-spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One 2014,9(4)","journal-title":"PLoS One"},{"key":"ref=6","first-page":"236","volume":"2","author":"Jain P.K.","year":"2012","unstructured":"Jain P.K.; Joshi H.; Coumarin: chemical and pharmacological profile. J Appl Pharm Sci 2012,2(6),236-240","journal-title":"J Appl Pharm Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/molecules22122072","volume":"22","author":"Bouasla S.","year":"2017","unstructured":"Bouasla S.; Amaro-Gahete J.; Esquivel D.; L&#xF3;pez M.I.; Jim&#xE9;nez-Sanchidri&#xE1;n C.; Teguiche M.; Romero-Salguero F.J.; Coumarin derivatives solvent-free synthesis under microwave irradiation over heterogeneous solid catalysts. Molecules 2017,22(12),2072","journal-title":"Molecules"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","volume":"20","author":"Anand P.","year":"2012","unstructured":"Anand P.; Singh B.; Singh N.; A review on coumarins as acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Bioorg Med Chem 2012,20(3),1175-1180","journal-title":"Bioorg Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.1038\/srep11825","volume":"5","author":"Al-Amiery A.A.","year":"2015","unstructured":"Al-Amiery A.A.; Al-Majedy Y.K.; Kadhum A.A.H.; Mohamad A.B.; Novel macromolecules derived from coumarin: synthesis and antioxidant activity. Sci Rep 2015,5,11825","journal-title":"Sci Rep"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18052\/www.scipress.com\/ILCPA.47.94","volume":"47","year":"2015","unstructured":"Synthesis, characterization, antibacterial evaluation and molecular docking studies of 2-azetidinone derivatives as novel DNA gyrase inhibitors. Int Lett Chem Phys Astro S. DarlinQuine2015,47,94-108","journal-title":"Int Lett Chem Phys Astro"},{"key":"ref=11","first-page":"235","volume":"5","author":"Reddy D.R.","year":"2013","unstructured":"Reddy D.R.; Namratha R.J.; Synthesis and biological evaluation of 6-fluoro benzothiazole substituted pyrazoloazetidinones. Der. PharmaChem 2013,5,235-240","journal-title":"PharmaChem"},{"key":"ref=12","first-page":"41","volume":"1","author":"Srinivas S.","year":"2012","unstructured":"Srinivas S.; Aparna V.; Rajkamal B.; Saikiran G.; Synthesis and antimicrobial evaluation of some novel quinolone incorporated azetidinones. Thiazolidinones. JPSI 2012,1,41-43","journal-title":"JPSI"},{"key":"ref=13","first-page":"324","volume":"4","author":"Naik P.J.","year":"2013","unstructured":"Naik P.J.; Parekh D.V.; Desai P.S.; Synthesis and biological evaluation of azitidinone and their derivative as antimicrobial agents. Adv Appl Sci Res 2013,4,324-329","journal-title":"Adv Appl Sci Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.1016\/j.bmc.2008.06.035","volume":"16","author":"O\u2019Driscoll M.","year":"2008","unstructured":"O\u2019Driscoll M.; Greenhalgh K.; Young A.; Turos E.; Dickey S.; Lim D.V.; Studies on the antifungal properties of N-thiolated &#x3B2;-lactams. Bioorg Med Chem 2008,16(16),7832-7837","journal-title":"Bioorg Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0976-9668.107260","volume":"4","author":"Thakur P.K.","year":"2013","unstructured":"Thakur P.K.; Kumar J.; Ray D.; Anjum F.; Hassan M.I.; Search of potential inhibitor against New Delhi metallo-beta-lactamase 1 from a series of antibacterial natural compounds. J Nat Sci Biol Med 2013,4(1),51-56","journal-title":"J Nat Sci Biol Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/cbdd.12225","volume":"83","author":"Raj R.","year":"2014","unstructured":"Raj R.; Biot C.; Carr&#xE8;re-Kremer S.; Kremer L.; Gu&#xE9;rardel Y.; Gut J.; Rosenthal P.J.; Kumar V.; 4-Aminoquinoline-&#x3B2;-lactam conjugates: synthesis, antimalarial, and antitubercular evaluation. Chem Biol Drug Des 2014,83(2),191-197","journal-title":"Chem Biol Drug Des"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1021\/jm9600196","volume":"39","author":"Reddy P.A.","year":"1996","unstructured":"Reddy P.A.; Hsiang B.C.; Latifi T.N.; Hill M.W.; Woodward K.E.; Rothman S.M.; Ferrendelli J.A.; Covey D.F.; 3,3-Dialkyl- and 3-alkyl-3-benzyl-substituted 2-pyrrolidinones: a new class of anticonvulsant agents. J Med Chem 1996,39(9),1898-1906","journal-title":"J Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"0069","DOI":"10.1055\/s-2002-19326","volume":"2002","author":"Alonso E.","year":"2002","unstructured":"Alonso E.; delPozo C.; Gonzalez J.; Synthesis of &#x3B1;, &#x3B1;-disubstituted &#x3B2;-amino esters and peptide derivatives. Syn Lett 2002,2002(01),0069-0072","journal-title":"Syn Lett"},{"key":"ref=19","first-page":"183","volume":"38B","author":"Srivastava S.K.","year":"1999","unstructured":"Srivastava S.K.; Srivastava S.; Srivastava S.D.; Synthesis of new carbazolyl-thiadiazol-2-oxo-azetidines: Antimicrobial, anticonvulsant and anti-inflammatory agents. Curr Res Bioorg Org Chem 1999,38B,183-187","journal-title":"Curr Res Bioorg Org Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1016\/S0040-4039(00)88543-3","volume":"31","author":"Skiles J.W.","year":"1990","unstructured":"Skiles J.W.; McNeil D.; Spiro indolinone beta-lactams, inhibitors of poliovirus and rhinovlrus 3C-proteinases. Tetrahedron Lett 1990,31(50),7277-7280","journal-title":"Tetrahedron Lett"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/chin.199547230","volume":"26","author":"Vashi B.S.","year":"1990","unstructured":"Vashi B.S.; Mehta D.S.; Shah V.H.; Synthesis and biological activity of 4\u2010Thiazolidinones, 2\u2010Azetidinones, 4\u2010Imidazolinone Derivatives Having Thymol Moiety. ChemInform 1990,26(47),1995","journal-title":"ChemInform"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1021\/jo9704366","volume":"62","author":"Wu G.","year":"1997","unstructured":"Wu G.; Tormos W.; A catalytic asymmetric synthesis of a spirofusedazetidinone as a cholesterol absorption inhibitor. J Org Chem 1997,62(18),6412-6414","journal-title":"J Org Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cbdv.200490173","volume":"2","author":"Lagoja I.M.","year":"2005","unstructured":"Lagoja I.M.; Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers 2005,2(1),1-50","journal-title":"Chem Biodivers"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","volume":"8","author":"De Clercq E.","year":"1987","unstructured":"De Clercq E.; Sakuma T.; Baba M.; Pauwels R.; Balzarini J.; Rosenberg I.; Hol&#xFD; A.; Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Res 1987,8(5-6),261-272","journal-title":"Antiviral Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0223-5234(02)00009-0","volume":"38","author":"Bekhit A.A.","year":"2003","unstructured":"Bekhit A.A.; Fahmy H.T.; Rostom S.A.; Baraka A.M.; Design and synthesis of some substituted 1H-pyrazolyl-thiazolo[4,5-d]pyrimidines as anti-inflammatory-antimicrobial Agents. Eur J Med Chem 2003,38(1),27-36","journal-title":"Eur J Med Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.ejmech.2007.08.004","volume":"43","author":"Virsodia V.","year":"2008","unstructured":"Virsodia V.; Pissurlenkar R.R.; Manvar D.; Dholakia C.; Adlakha P.; Shah A.; Coutinho E.C.; Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides. Eur J Med Chem 2008,43(10),2103-2115","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1021\/jm00177a025","volume":"23","author":"Grivsky E.M.","year":"1980","unstructured":"Grivsky E.M.; Lee S.; Sigel C.W.; Duch D.S.; Nichol C.A.; Synthesis and antitumor activity of 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine. J Med Chem 1980,23(3),327-329","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1021\/jm00358a016","volume":"26","author":"Lin T.S.","year":"1983","unstructured":"Lin T.S.; Mancini W.R.; Synthesis and antineoplastic activity of 3\u2032-azido and 3\u2032-amino analogues of pyrimidine deoxyribonucleoside. J Med Chem 1983,26(4),544-548","journal-title":"J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1476-5381.1951.tb00634.x","volume":"6","author":"Falco E.A.","year":"1951","unstructured":"Falco E.A.; Goodwin L.G.; Hitchings G.H.; Rollo I.M.; Russell P.B.; 2:4-diaminopyrimidines- a new series of antimalarials. Br J Pharmacol Chemother 1951,6(2),185-200","journal-title":"Br J Pharmacol Chemother"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0223-5234(89)90001-9","volume":"24","author":"Monge A.","year":"1989","unstructured":"Monge A.; Martinez-Merino V.; Sanmartin C.; Fernandez F.J.; Ochoa M.C.; Bellver C.; Artigas P.; Fernandez-Alvarez E.; 2-Arylamino-4-oxo-3, 4-dihydropyrido [2, 3-d] pyrimidines: synthesis and diuretic activity. Eur J Med Chem 1989,24(3),209-216","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0968-0896(00)00272-8","volume":"9","author":"Bruno O.","year":"2001","unstructured":"Bruno O.; Schenone S.; Ranise A.; Bondavalli F.; Barocelli E.; Ballabeni V.; Chiavarini M.; Bertoni S.; Tognolini M.; Impicciatore M.; New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening. Bioorg Med Chem 2001,9(3),629-636","journal-title":"Bioorg Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/B978-0-12-397176-0.00003-0","author":"Stocks M.","year":"2013","unstructured":"Stocks M.;  The small molecule drug discovery process\u2013from target selection to candidate selection 2013,81-126","journal-title":"The small molecule drug discovery process\u2013from target selection to candidate selection"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/molecules21091156","volume":"21","author":"Hafez H.N.","year":"2016","unstructured":"Hafez H.N.; El-Gazzar A.R.; Synthesis and biological evaluation of N-pyrazolyl derivatives and pyrazolopyrimidine bearing a biologically active sulfonamide moiety as potential antimicrobial agent. Molecules 2016,21(9),1156","journal-title":"Molecules"},{"key":"ref=34","first-page":"849","volume":"8","author":"Chandrasekaran K.","year":"2016","unstructured":"Chandrasekaran K.; Biosimilarity versus manufacturing change: two distinct concepts. J Chem Pharm Res 2016,8,849-861","journal-title":"J Chem Pharm Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/molecules22101685","volume":"22","author":"Polaquini C.R.","year":"2017","unstructured":"Polaquini C.R.; Torrezan G.S.; Santos V.R.; Nazar&#xE9; A.C.; Campos D.L.; Almeida L.A.; Silva I.C.; Ferreira H.; Pavan F.R.; Duque C.; Regasini L.O.; Antibacterial and antitubercular activities of cinnamylideneacetophenones. Molecules 2017,22(10),1685","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"22188","DOI":"10.3390\/molecules201219841","volume":"20","author":"Tamaian R.","year":"2015","unstructured":"Tamaian R.; Mo\u0163 A.; Silaghi-Dumitrescu R.; Ionu\u0163 I.; Stana A.; Oniga O.; Nastas\u0103 C.; Benedec D.; Tiperciuc B.; Study of the relationships between the structure, lipophilicity and biological activity of some thiazolyl-carbonyl-thiosemicarbazides and thiazolyl-azoles. Molecules 2015,20(12),22188-22201","journal-title":"Molecules"},{"key":"ref=37","unstructured":"SwissADME(Available from: )"},{"key":"ref=38","unstructured":"PreADMET(Available from: )"},{"key":"ref=39","unstructured":"ProTox-II(Available from: )"},{"key":"ref=40","unstructured":"UCSF Chimera (Available from: )"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/178908","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/178908\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/178908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T15:53:17Z","timestamp":1647359597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178908\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409916666200131142619","relation":{},"ISSN":["1573-4099"],"issn-type":[{"type":"print","value":"1573-4099"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}